Search results for CONTACT COLASHIP.SHOP TO
Results found
Displaying items 1111 - 1120 of 1536 in total
-
Export opportunity
Faunistic mapping and potential assessments as well as species protection law
Faunistic mapping and assessment of potential as well as species conservation report; Scope of service:; 3.1: Faunistic mapping and assessment of potential; Me…
-
Export opportunity
16--servovalve,hydrauli
CONTACT INFORMATION|4|N733.09|N00383|215-697-2243|ELISE.ANZINI@NAVY.MIL| ITEM UNIQUE IDENTIFICATION AND VALUATION (JAN 2023)|19|||||||||||||||||||| HIGHER-LEVE…
-
Export opportunity
Patriot missile spares (multiple nsns) – sole source lockheed Martin missles & fire control
View Changes Amendment 0014 change proposal due date to 13 February 2025. _______________________________________________________________________ Amendment 00…
-
Export opportunity
Drugs
Conclusion of non-exclusive discount contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient tofacitinib (L04AA29) withi…
-
Export opportunity
Drugs
Conclusion of non-exclusive discount agreements pursuant to Sections 130a (8)/130c (1) SGB V for drugs with the active ingredient Natalizumab (L04AA23), s.c. d…
-
Export opportunity
Pharmaceuticals
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8/130c para. 1 SGB V for medicinal products with the active ingredient s…
-
Export opportunity
Pharmaceuticals
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8/130c para. 1 SGB V for medicinal products with the active ingredient f…
-
Export opportunity
Pharmaceuticals
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8/130c para. 1 SGB V for medicinal products with the active ingredient l…
-
Export opportunity
Pharmaceuticals
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8/130c para. 1 SGB V for medicinal products with the active ingredient g…
-
Export opportunity
Pharmaceuticals
Conclusion of non-exclusive discount agreements in accordance with Sections 130a para. 8/130c para. 1 SGB V for medicinal products with the active ingredient t…